
ALC · NYSE
The supplied record does not provide enough information to describe Alcon’s products, operating segments, customer base, geographic footprint, or current scale without adding unsupported facts. It identifies Alcon as the issuer of the ALC shares and reports fiscal 2010 revenue of $7.2 billion and net income of $2.2 billion, compared with $6.5 billion and $2.0 billion, respectively, in fiscal 2009. Segment contributions, customer categories, employee count, and more recent operating figures are not included in the evidence.
Alcon rose 2.72%, from $69.11 to $70.99, over the reported period. The stock initially advanced to $69.65 on July 29, was nearly unchanged on July 30, and then gave back those gains to close at $68.94 on July 31. It reversed higher on August 3 and extended the move on August 4, gaining $2.05 across the final two sessions. The supplied evidence identifies no company-specific announcement, earnings result, guidance change, contract, or analyst action that explains the rebound. Instead, trading occurred as investors looked ahead to Alcon’s quarter ended June 2026, while separate Zacks articles highlighted valuation and recent options activity. No broader market driver is provided.
Alcon: A Re-Rating In EyesightEye surgeons get a viewing zone up to six times larger from Alcon's new microscope.